Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: Correlation with serumIGF-I levels

Journal of Endocrinological Investigation

Volumn 36, Issue 10, 2013, Pages 853-859

  Mori, K ^a   Iwasaki, Y ^a   Kawasaki Ogita, Y ^a   Honjo, S ^a   Hamamoto, Y ^a   Tatsuoka, H ^a   Fujimoto, K ^a   Ikeda, H ^a   Wada, Y ^a   Takahashi, Y ^a   Takahashi, J ^a   Koshiyama, H ^a,b  

^a Kitano Hospital   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acromegaly; HOMA IR; IGF I; Insulin resistance

Indexed keywords

GLUCOSE; METFORMIN; MITIGLINIDE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GROWTH HORMONE SECRETING ADENOMA; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; YOUNG ADULT;

ACROMEGALY; ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PITUITARY NEOPLASMS; POSTOPERATIVE PERIOD; PROGNOSIS; SPHENOID SINUS; YOUNG ADULT;

EID: 84891685968     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/8964     Document Type: Article

References (28)

1. Melmed S, Colao A, Barkan A, et al. Guidelines for acromegaly management. J Clin Endocrinol Metab 2009, 94: 1509-17.
2. Clemmons DR. Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 2002, 5: 181-3.
3. Yakar S, Setser J, Zhao H, et al. Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 2004, 113: 96-105.
4. del Rincon JP, Iida K, Gaylinn BD, et al. Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 2007, 56: 1638-46.
5. Sasaki-Suzuki N, Arai K, Ogata T, et al. Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 2009, 284: 6061-70.
6. Lindberg-Larsen R, Møller N, Schmitz O, et al. The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly. J Clin Endocrinol Metab 2007, 92: 1724-8.
7. Yakar S, Liu JL, Fernandez AM, et al. Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001, 50: 1110-8.
8. Haluzik M, Yakar S, Gavrilova O, Setser J, Boisclair Y, LeRoith D. Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 2003, 52: 2483-9.
9. Boulware SD, TamborlaneWV, Rennert NJ, Gesundheit N, Sherwin RS. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults. J Clin Invest 1994, 93: 1131-9.
10. Morrow LA, O'Brien MB, Moller DE, Flier JS, Moses AC. Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance. J Clin Endocrinol Metab 1994, 79: 205-10.
11. Melmed S. Acromegaly. N Engl J Med 2006, 355: 2558-73.
12. Takahashi JA, Shimatsu A, Nakao K. Early postoperative indicators of late outcome in acromegalic patients. Clin Endocrinol (Oxf) 2004, 60: 366-74.
13. Kinoshita Y, Fujii H, Takeshita A, et al. Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic β-cell function is preserved. Eur J Endocrinol 2011, 164: 467-73.
14. Tzanela M, Vassiliadi DA, Gavalas N, et al. Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues. Clin Endocrinol (Oxf) 2011, 10: 1365-2265.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012, 35 (Suppl 1): S64-71.
16. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000, 23: 57-63.
17. Rhee SY, Chon S, Oh S, et al. Insulin secretion and insulin resistance in newly diagnosed, drug naive prediabetes and type 2 diabetes patients with/without metabolic syndrome. Diabetes Res Clin Pract 2007, 76: 397-403.
18. Isojima T, Shimatsu A, Yokota S, et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J 2012, 19: 1-10.
19. Shimatsu A, Fujieda K, Hanyu K, et al. Clinical evaluation of serum IGF-I, IGF-II and IGFBP-3 measured by IRMA kits in adulthood. Horumon to Rinsho 1996, 44: 1129-38 (in Japanese).
20. Fukuoka H, Takahashi Y, Iida K, et al. Low serum IGF-1/GH ratio is associated with abnormal glucose tolerance in acromegaly. Horm Res 2008, 69: 165-71.
21. Wasada T, Aoki K, Sato A, et al. Assessment of insulin resistance in acromegaly associated with diabetes mellitus before and after transsphenoidal adenomectomy. Endocr J 1997, 44: 617-20.
22. Luger A, Prager R, Gaube S, Graf H, Klauser R, Schernthaner G. Decreased peripheral insulin sensitivity in acromegalic patients. Exp Clin Endocrinol 1990, 95: 339-43.
23. Dupuis J, Langenberg C, Prokopenko I, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010, 42: 105-16.
24. Feelders RA, Bidlingmaier M, Strasburger CJ, et al. Postoperative evaluation of patients with acromegaly: clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels. J Clin Endocrinol Metab 2005, 90: 6480-9.
25. Kristof RA, Neuloh G, Redel L, et al. Reliability of the oral glucose tolerance test in the early postoperative assessment of acromegaly remission. J Neurosurg 2002, 97: 1282-6.
26. Niculescu D, Purice M, Coculescu M. Insulin-like growth factor-1 correlates more closely than growth hormone with insulin resistance and glucose intolerance in patients with acromegaly. Pituitary 2013, 16: 168-74.
27. Coculescu M, Niculescu D, Lichiardopol R, Purice M. Insulin resistance and insulin secretion in non-diabetic acromegalic patients. Exp Clin Endocrinol Diabetes 2007, 115: 308-16.
28. Kaltsas GA, Isidori AM, Florakis D, et al. Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 2001, 86: 1645-52.